Lymphoma Non-Hodgkin's, Adult: Difference between revisions
From OncoWiki
Jump to navigationJump to search
m (1 revision) |
|||
Line 31: | Line 31: | ||
[[EPIC]]<BR> | [[EPIC]]<BR> | ||
[[EPOCH]]<BR> | [[EPOCH]]<BR> | ||
[[EPOCH-DA]]<BR> | |||
[[R-EPOCH]]<BR> | [[R-EPOCH]]<BR> | ||
[[ESHAP]]<BR> | [[ESHAP]]<BR> |
Revision as of 06:53, 29 August 2013
Regimens
Indolent NHL
- Bendamustine
- Chlorambucil
- Cyclophosphamide
- Fludarabine
- Rituximab
- Rituximab, Bendamustine, Bortezomib
- CVP
- R-CVP
- FC
- FCM
- R-FCM
- FN
- FND
- MCP
- R-MCP
- RC
Aggressive NHL
CHOP
R-CHOP
CHOP-14
CHOEP-14
CEOP
CNOP
COPP
DHAP
DHAX
EPIC
EPOCH
EPOCH-DA
R-EPOCH
ESHAP
GEM-P
GEM-Vinorelbine-Pred
HyperCVAD
ICE
RICE
IMVP-16
MACOP-B
VNCOP-B
MIME
MINE/ESHAP
m-BACOD
MiCMA
SMILE
Mantle Cell Lymphoma
Bendamustine
R-CHOP
R-FCM
R-FCM + maintenance R
Bortezomib
R-GemOx
HyperCVAD
Pre-B or T lymphoblastic lymphoma
Burkitt's Lymphoma
- BFM B-Cell (German protocol)
- CODOX-M/IVAC
- Modified CODOX-M
- CALGB 9251
Primary CNS Lymphoma
High dose Methotrexate
Bonn protocol
RTOG study 93-10 (deAngelis regime)
Temozolomide